Fecal microbiota transplantation boosts survival in metastatic colorectal cancer treatment

Fecal microbiota transplantation boosts survival in metastatic colorectal cancer treatment
A recent study in eClinicalMedicine found that fecal microbiota transplantation, combined with fruquintinib and tislelizumab, significantly improved survival ra...
In a recent study published in eClinicalMedicine, researchers assess the use of fecal microbiota transplantation to enhance the efficacy of anti-programmed cell... Read More



Related Stories

See All